GNMX was created on 2026-05-06 by Corgi. The fund's investment portfolio concentrates primarily on theme equity. GNMX seeks capital appreciation through a portfolio of companies tiedto thegenomics and precision medicine value chain, from sequencing platforms and bioinformatics engines to gene editors, molecular diagnostics, targeted therapies, and clinical data platforms.